Home »
A majority of patients with Parkinson disease (PD) experiencing “off” episodes successfully tolerated titration to an effective and tolerable dose of sublingual apomorphine film (SL-apo; Kynmobi, Sunovion Pharmaceuticals) without the use of antiemetic medication, new research shows. “The bottom line was that the majority of patients did not have dose-limiting nausea or vomiting,” co-investigator William […]
Parkinson’s disease affects seven to ten million patients in Western societies – with an upward trend. Patients suffer from symptoms such as tremors, gait and speech disorders, and memory loss. Digital technologies have the potential to change the understanding and treatment of Parkinson’s disease fundamentally. But before they can be implemented in clinical practice, their […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART CLOMIPRAMINE Contains the active ingredient, clomipramine (as clomipramine hydrochloride) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about clomipramine. It does not contain all the available information.It […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SIFROL CMI0035-15 Tablets pramipexole dihydrochloride monohydrate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Sifrol. It does not contain all the available information. It does not take the place of talking to your doctor or […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CO-DIOVAN® Valsartan/hydrochlorothiazide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Co-Diovan. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BLOOMS THE CHEMISTFLUOXETINE CAPSULES Fluoxetine (as fluoxetine hydrochloride) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about fluoxetine. It does not contain all the available information. It does not take the place of talking to your […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LIORESAL® INTRATHECAL baclofen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Lioresal Intrathecal. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VERSION: A03-1802201 SUPERSEDES: A02-090818 25, 50, 100 mg capsules Milnacipran hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Joncia®. It does not contain all the available information. It does not take the place of […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DOTHEP contains the active ingredient dothiepin hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Dothep. It does not contain all the available information.It does not take the place of talking to your doctor or […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-VENLAFAXINE XR CAPSULES Venlafaxine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about venlafaxine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. […]